PureTech Health plc Financials

PureTech Health Stock Summary

PureTech Health competes with Apellis Pharmaceuticals, Terns Pharmaceuticals, Day One, Blueprint Medicines, and Amylyx Pharmaceuticals. PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PURETECH HEALTH operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 95 people.

PureTech Health Key Financial Ratios

There are many critical financial ratios that PureTech Health's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that PureTech Health plc reports annually and quarterly.

PureTech Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining PureTech Health's current stock value. Our valuation model uses many indicators to compare PureTech Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PureTech Health competition to find correlations between indicators driving PureTech Health's intrinsic value. More Info.PureTech Health plc is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PureTech Health's earnings, one of the primary drivers of an investment's value.

PureTech Health Market Pulse

Along with financial statement analysis, the daily predictive indicators of PureTech Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PureTech Health plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of PureTech Health plc based on widely used predictive technical indicators. In general, we focus on analyzing PureTech Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PureTech Health's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

If you are still planning to invest in PureTech Health plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PureTech Health's history and understand the potential risks before investing.